Lifespanology

Tag: health

  • Difficult to swallow…Until Now-History in Tablet Form

    Novo Nordisk (NVO) FDA Approval of Oral Wegovy- a defining moment for Obesity Pharmacology Investment View: STRATEGIC POSITIVE / STRUCTURAL INFLECTION POINTSector: Global Pharmaceuticals – Metabolic & ObesityCatalyst: FDA approval of first-ever oral GLP-1 weight-loss therapy Executive Summary The US FDA approval of oral Wegovy (semaglutide) marks a historic inflection point for obesity treatment and for Novo Nordisk’s long-term competitive positioning. This…